Literature DB >> 6210326

Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study.

J W Said, A F Sassoon, I P Shintaku, S Banks-Schlegel.   

Abstract

Involucrin is a precursor of cross-linked protein of human stratum corneum, and its appearance in the upper layers of the epidermis is a function of the normal differentiation of the keratinocyte. Cases of basal cell and squamous cell carcinoma were evaluated for the presence of involucrin using immunoperoxidase techniques on paraffin sections. Basal cell carcinomas were negative for involucrin with staining restricted to squamous horn cysts, while squamous cell carcinomas stained strongly, particularly in large keratinized cells. Cases of squamous cell carcinoma in situ (Bowen's disease) revealed increased staining for involucrin with staining of dyskeratotic cells at all levels in the epithelium. Abnormal patterns of staining were also noted in non-neoplastic epidermis adjacent to carcinomas. Immunohistochemical staining for involucrin identifying abnormal or premature keratinization is a sensitive marker for dyskeratosis in squamous epithelia and may have applications in the histopathologic evaluation of skin specimens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210326     DOI: 10.1111/1523-1747.ep12260937

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

Review 1.  Distribution of epithelial antigens in the human uterine cervix: a review.

Authors:  V Serra; A Ramirez; M C Marzo; F Valcuende; C Lara; A Castells; F Bonilla-Musoles
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Immunohistochemical observations of keratins, involucrin, and epithelial membrane antigen in urinary bladder carcinomas from patients infected with Schistosoma haematobium.

Authors:  S Fukushima; N Ito; M N el-Bolkainy; H N Tawfik; Y Tatemoto; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Involucrin expression in adnexal skin tumours. An immunohistological study.

Authors:  J Kanitakis; G Zambruno; J Viac; J Thivolet
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

4.  Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell carcinomas of the skin.

Authors:  A P Lavrijsen; L M Tieben; M Ponec; J G van der Schroeff; G N van Muijen
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy.

Authors:  Yolanda Gilaberte; Laura Milla; Nerea Salazar; Jesús Vera-Alvarez; Omar Kourani; Alejandra Damian; Viviana Rivarola; Maria José Roca; Jesús Espada; Salvador González; Angeles Juarranz
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

6.  Involucrin expression in breast carcinomas: an immunohistochemical study.

Authors:  C Schmid; K Zatloukal; A Beham; H Denk
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Arsenic-induced malignant transformation of human keratinocytes: involvement of Nrf2.

Authors:  Jingbo Pi; Bhalchandra A Diwan; Yang Sun; Jie Liu; Wei Qu; Yuying He; Miroslav Styblo; Michael P Waalkes
Journal:  Free Radic Biol Med       Date:  2008-06-03       Impact factor: 7.376

8.  Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen.

Authors:  Vera L Martins; Jashmin J Vyas; Mei Chen; Karin Purdie; Charles A Mein; Andrew P South; Alan Storey; John A McGrath; Edel A O'Toole
Journal:  J Cell Sci       Date:  2009-05-12       Impact factor: 5.285

9.  Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix.

Authors:  M Cintorino; S Syrjänen; P Leoncini; E Bellizzi De Marco; R Petracca; V Pallini; P Tosi; R Mäntyjärvi; K Syrjänen
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

10.  Involucrin expression in urinary bladder carcinoma.

Authors:  M Asamoto; S Fukushima; H Horike; Y Tatemoto; M Mori
Journal:  Urol Res       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.